Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors

The role of AMPA and NMDA receptors in the shell of the nucleus accumbens in turning behaviour of rats was investigated. Unilateral injection of the AMPA receptor agonist, AMPA (0.25, 0.4, 0.5 and 1 mug), into the shell of the nucleus accumbens dose-dependently produced contraversive pivoting, namely tight head-to-tail turning marked by abnormal hindlimb backward stepping, while injection of AMPA (0.5 mug) into the core produced only a marginal effect. This shell-specific AMPA effect was dose-dependently inhibited by the AMPA receptor antagonist, NBQX (1 and 10 ng), which alone did not produce turning behaviour. The AMPA-induced pivoting was also dose-dependently inhibited by the non-competitive NMDA receptor antagonist, MK-801 (0.1 and 0.5 mug). Neither MK-801 (0.1, 0.5 and 5 mug) nor the NMDA receptor agonist, NMDA (0.5 and 1 mug), injected unilaterally into the shell, produced turning behaviour. Unilateral injection of a mixture of dopamine D, (SKF 38393, 5 mug) and D-2 (quinpirole, 10 mug) receptor agonists into the shell has been found to elicit contraversive pivoting. The dopamine D-1/D-2 receptor antagonist, cis-(Z)-flupentixol (1 and 10 mug), injected into the shell, in doses known to block dopamine D-1/D-2 receptor-mediated pivoting, also significantly inhibited AMPA (0.5 mug)-induced pivoting. Moreover, both NBQX (I and 10 ng) and MK-801 (0.1 and 0.5 mug), injected into the shell, significantly inhibited dopamine D-1/D-2 receptor-mediated pivoting. It is therefore concluded that unilateral stimulation of AMPA receptors in the shell of the nucleus accumbens can elicit contraversive pivoting, and that both AMPA and dopamine D-1/D-2 receptors play a critical role in shell-specific pivoting in contrast to NMDA receptors that at best play only a modulatory role. (C) 2002 Elsevier Science Ltd. All rights reserved.